(Q38542575)

4 September 2017

1 reference

title

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (English)

1 reference

4 September 2017

1 reference

1

0 references

Pärt Peterson

series ordinal

2

0 references

publication date

5 July 2015

1 reference

Journal of Clinical Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

35

1 reference

4 September 2017

issue

5

1 reference

4 September 2017

page(s)

463-478

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-015-0176-y

4 September 2017

exact match

0 references

cites work

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

APS-I/APECED: the clinical disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Positional cloning of the APECED gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Polyglandular autoimmune syndrome type I among Iranian Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndrome type 1 (APS I) in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Kidney involvement in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in a Finnish cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Human APECED; a Sick Thymus Syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Deletional tolerance mediated by extrathymic Aire-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Transcriptional regulation by AIRE: molecular mechanisms of central tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Self-representation in the thymus: an extended view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire regulates negative selection of organ-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Projection of an immunological self shadow within the thymus by the aire protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire-dependent thymic development of tumor-associated regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

AIRE-PHD fingers are structural hubs to maintain the integrity of chromatin-associated interactome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire's partners in the molecular control of immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Cooperative activation of transcription by autoimmune regulator AIRE and CBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Patient mutation in AIRE disrupts P-TEFb binding and target gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Contrasting models for the roles of Aire in the differentiation program of epithelial cells in the thymic medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Which model better fits the role of aire in the establishment of self-tolerance: the transcription model or the maturation model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The many faces of aire in central tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Lymphopenia-induced proliferation in aire-deficient mice helps to explain their autoimmunity and differences from human patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Temporal lineage tracing of Aire-expressing cells reveals a requirement for Aire in their maturation program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Functional analysis of SAND mutations in AIRE supports dominant inheritance of the G228W mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Clinical review 93: Autoimmune polyglandular syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

In vivo analysis of helper T cell responses in patients with autoimmune polyendocrinopathy - candidiasis - ectodermal dystrophy provides evidence in support of an IL-22 defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Cellular immunity and immunopathology in autoimmune Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

21-Hydroxylase, a major autoantigen in idiopathic Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Orthotopic liver transplantation for acute liver failure secondary to autoimmune hepatitis in a child with autoimmune polyglandular syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Chronic active hepatitis in the type I polyglandular autoimmune syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Absence of some common organ-specific and non-organ-specific autoimmunity in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Gastrointestinal manifestations in APECED syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Loss of enteroendocrine cells in autoimmune-polyendocrine-candidiasis-ectodermal-dystrophy (APECED) syndrome with gastrointestinal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Classification and functions of enteroendocrine cells of the lower gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Identification of tryptophan hydroxylase as an intestinal autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Gastrointestinal Autoimmunity Associated With Loss of Central Tolerance to Enteric α-Defensins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Post-splenectomy and hyposplenic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Aire and T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Autoimmune Regulator-1 Messenger Ribonucleic Acid Analysis in a Novel Intronic Mutation and Two Additional NovelAIREGene Mutations in a Cohort of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0176-Y

ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

21 January 2018

1 reference

12 December 2020

Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1

1 reference

12 December 2020

Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I

1 reference

12 December 2020

Update on autoimmune polyendocrine syndromes (APS).

1 reference

12 December 2020

21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison’s disease

1 reference

12 December 2020

IL-7 dysregulation and loss of CD8+ T cell homeostasis in the monogenic human disease autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

1 reference

12 December 2020

Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis

1 reference

12 December 2020

Measuring Autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by Radioligand Binding Assay Using Fusion Proteins

1 reference

12 December 2020

Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease

1 reference

12 December 2020

Post-Aire Maturation of Thymic Medullary Epithelial Cells Involves Selective Expression of Keratinocyte-Specific Autoantigens

1 reference

12 December 2020

Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1

1 reference

12 December 2020

Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I

1 reference

12 December 2020

Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy

1 reference

12 December 2020

Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I

1 reference

12 December 2020

Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency

1 reference

12 December 2020

Autoimmunity to gastrointestinal endocrine cells in autoimmune polyendocrine syndrome type I

1 reference

12 December 2020

Mutational analysis of the autoimmune regulator (AIRE) gene in sporadic autoimmune Addison's disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I

1 reference

12 December 2020

Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)

1 reference

12 December 2020

Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence

1 reference

12 December 2020

Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy

1 reference

12 December 2020

AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype

1 reference

12 December 2020

Malignant disease presenting as Addison's disease

1 reference

12 December 2020

Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations

1 reference

12 December 2020

A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

1 reference

12 December 2020

Functional autoantibodies cause hypoparathyroidism

1 reference

12 December 2020

Oral and oesophageal squamous cell carcinoma – A complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)

1 reference

12 December 2020

Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab

1 reference

12 December 2020

Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I

1 reference

12 December 2020

Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease

1 reference

12 December 2020

Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1

1 reference

12 December 2020

Do NALP5 antibodies correlate with hypoparathyroidism in patients with APS-1?

1 reference

12 December 2020

T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency

1 reference

12 December 2020

AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED

1 reference

12 December 2020

Liver disease in polyglandular autoimmune disease type one: clinicopathologic study of three patients and review of the literature

1 reference

12 December 2020

Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

1 reference

12 December 2020

BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease

1 reference

12 December 2020

The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression

1 reference

12 December 2020

A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis.

1 reference

12 December 2020

10.1007/S10875-015-0176-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1049488465

0 references

1 reference